Participants with diets high in vitamin K1<\/sub> and vitamin K2<\/sub> have reduced risk for atherosclerotic CVD in adjusted analyses<\/p>\n<\/h3>\n <\/b><\/p>\n <\/b><\/p>\n MONDAY, Aug. 16, 2021 (HealthDay News) — Diets high in vitamin K1 <\/sub>and K2<\/sub> are inversely associated with the risk for atherosclerotic cardiovascular disease (ASCVD), according to a study published online Aug. 7 in the Journal of the American Heart Association<\/em>.<\/p>\n Jamie W. Bellinge, M.B.B.S., from the University of Western Australia in Perth, and colleagues conducted a prospective cohort study involving participants with no prior ASCVD who completed a food-frequency questionnaire at baseline and were followed for hospital admissions of ASCVD, ischemic heart disease, ischemic stroke, or peripheral artery disease. Intakes of vitamin K1<\/sub> and K2<\/sub> were estimated and their correlation with ASCVD hospitalizations was ascertained.<\/p>\n The researchers found that 8,726 of the 53,372 Danish citizens with a median age of 56 years were hospitalized for any ASCVD during 21 years of follow-up. After multivariable adjustments for relevant demographic covariates, participants with the highest versus the lowest vitamin K1<\/sub> intake had a reduced risk for ASCVD-related hospitalization (hazard ratio, 0.79). Similarly, the risk for an ASCVD-related hospitalization was reduced for participants with the highest versus the lowest vitamin K2<\/sub> intake (hazard ratio, 0.86).<\/p>\n “These findings shed light on the potentially important effect that vitamin K has on the killer disease and reinforces the importance of a healthy diet in preventing it,” Bellinge said in a statement.<\/p>\n Several authors disclosed financial ties to the biopharmaceutical and medical device industry.<\/p>\n